• Extracellular Disulfide Bonds Govern OATP1B1 Surface Functio

  2026-07-30

  This study systematically demonstrates that all extracellular cysteine residues in human OATP1B1 form disulfide bonds, which are crucial for its correct surface expression and transport activity. The findings refine our understanding of OATP1B1 structure-function relationships and support precise experimental approaches in transporter biology.

• LDH Cytotoxicity Assay Kit: Precision in Cell Damage Quantif

  2026-07-30

  The LDH Cytotoxicity Assay Kit empowers researchers to accurately measure cell cytotoxicity and apoptosis, providing a reliable, non-radioactive alternative for advanced biocompatibility studies. Its robust protocol and compatibility with diverse cell models set a new standard for reproducibility in nanomaterial and drug safety screening.

• AICAR: AMPK Activation and Inflammation Inhibition in Resear

  2026-07-29

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) is a potent, cell-permeable AMPK activator that modulates energy metabolism and inhibits inflammation. Its efficacy is benchmarked in metabolic disease and airway inflammation models, with reproducible protocol parameters verified in both in vitro and in vivo research.

• Meropenem: Advanced Strategies for Gram-Negative Research Mo

  2026-07-29

  Explore Meropenem as an ultra-broad-spectrum β-lactam antibiotic carbapenem for innovative Gram-negative and Gram-positive bacterial infection models. This article offers a deeper scientific analysis and practical workflow insights beyond standard protocols.

• Standardized Whole-Blood Stimulation for Immunometabolic Pro

  2026-07-28

  The referenced study introduces a rigorously standardized protocol for analyzing immune responses by stimulating whole blood with metabolic modulators. This approach enables precise dissection of how metabolic inhibitors, such as dehydrogenase inhibitors, influence cytokine production and immune cell activation, advancing reproducibility and scalability in immunometabolism research.

• Fingolimod (FTY720): Applied Workflows for Immune Engineerin

  2026-07-28

  Fingolimod (FTY720) is redefining immune modulation and neuroprotection in both translational immunology and cell therapy. This guide delivers actionable protocols, troubleshooting insights, and a bridge to the latest in vivo CAR-T-mimicry breakthroughs—empowering research teams to push the frontiers of S1P-targeted interventions.

• Ruthenium Red in Mechanotransduction: Advanced Insights for

  2026-07-27

  Explore how Ruthenium Red, a leading Ca2+ transport inhibitor, enables precise dissection of mechanotransduction and cytoskeleton-dependent autophagy. This in-depth review highlights novel considerations for calcium signaling research and assay optimization.

• Direct Mouse Genotyping Kit Plus: Fast, Reliable Assays for

  2026-07-27

  The Direct Mouse Genotyping Kit Plus streamlines mouse genetic research with rapid, purification-free DNA extraction and high-fidelity PCR, enabling robust genotyping, transgene detection, and animal colony screening. Its optimized workflow allows researchers to bypass bottlenecks in high-throughput studies and accelerate discoveries in disease model validation.

• EdU Flow Cytometry Assay Kits (Cy3) for Proliferation and Ge

  2026-07-26

  EdU Flow Cytometry Assay Kits (Cy3) enable rapid, multiplexed quantification of cell proliferation and DNA synthesis—outperforming legacy BrdU assays by preserving sample integrity and streamlining workflows. Their robust click chemistry platform supports sensitive cell cycle analysis and advanced genotoxicity testing, empowering translational and preclinical research.

• ER Stress and Cytokine Storm Drive Prometastatic Tumor State

  2026-07-25

  Conod et al. reveal that tumor cells escaping impending death adopt stable prometastatic states, orchestrated by ER stress pathways and a potent cytokine storm. This mechanistic insight clarifies how metastases may arise after cell-death-inducing treatments, suggesting new targets and experimental strategies for metastasis prevention.

• Fingolimod (FTY720): S1P Receptor Modulation in MS and CNS S

  2026-07-24

  Fingolimod (FTY720) is a sphingosine-1-phosphate (S1P) receptor modulator with validated immunomodulatory and neuroprotective actions. It is approved for multiple sclerosis (MS) and serves as a research standard for lymphocyte egress inhibition and CNS BDNF upregulation.

• iTBS Improves Motor Function and Reduces Neuroinflammation i

  2026-07-24

  This study demonstrates that intermittent theta-burst stimulation (iTBS) improves motor coordination and attenuates neuroinflammation and pathogenic protein aggregation in a mouse model of spinocerebellar ataxia type 3 (SCA3/MJD). The findings highlight iTBS as a non-invasive neuromodulation strategy with disease-modifying potential, outperforming continuous TBS and providing new mechanistic insights into autophagy and inflammatory modulation.

• Ibuprofen as an Anti-Proliferative Agent: Advanced Workflows

  2026-07-23

  Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) is redefining colon cancer research as a potent anti-proliferative and apoptosis-inducing agent. This guide delivers protocol innovations, troubleshooting strategies, and fresh mechanistic insights to empower rigorous, reproducible experimentation with APExBIO’s Ibuprofen.

• Epoxomicin in Cellular PQC: Advanced Use in ER Stress Resear

  2026-07-23

  Explore how Epoxomicin, a potent proteasome inhibitor, empowers advanced research on protein quality control and ER stress. This article reveals new assay strategies and scientific insights distinct from existing guides.

• Applied Drug Repositioning with DiscoveryProbe FDA-approved

  2026-07-22

  The DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) empowers researchers to accelerate drug repositioning and pharmacological target identification by providing 2,320 pre-dissolved, regulatory-approved bioactive compounds for high-throughput screening. This article details practical workflows, troubleshooting strategies, and emerging evidence—such as the repurposing of loperamide for intracellular infections—demonstrating the library’s versatility across disease models.

15494 records 1/1033 page Next 12345 下5页 Last page